OscarBoutrosLahoudMD
Hematology • Brooklyn, NYHematologic Oncology
Director, Strategy and Network Operations, NYU Perlmutter Cancer Center – Hematology/Oncology; Section Chief, Hematology – NYU Brooklyn; Clinical Associate Professor of Medicine, NYU Grossman School of Medicine
Dr. Lahoud is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5718 2nd Ave
2nd Floor
Brooklyn, NY 11220Phone+1 646-754-8570Fax+1 646-754-8501
Summary
- Dr. Oscar Lahoud is a hematologic oncologist in New York, NY at NYU Langone Health. He received his medical degree from University of Michigan Medical School and has been in practice 8 years. He also speaks multiple languages, including French, Arabic, and German. He specializes in hematopoietic (bone marrow) stem cell transplantation and cellular therapies for the treatment of hematologic malignancies such as lymphoma, plasma cell disorders (multiple myeloma/amyloidosis), and leukemia.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2016 - 2017
Maimonides Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016- Maimonides Medical CenterResidency, Internal Medicine, 2009 - 2012
University of Michigan Medical SchoolClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2012 - 2026
NJ State Medical License 2021 - 2025
CT State Medical License 2023 - 2024
NC State Medical License 2020 - 2022
Publications & Presentations
PubMed
- A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation.Joshua A Fein, Agnes McAuliffe, Kimberly Fischer, Owen Brady, Sean M Devlin
Leukemia & Lymphoma. 2024-12-06 - Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity.Brian C Shaffer, Samantha Brown, Stephanie Chinapen, Kathryn E Mangold, Oscar Lahoud
Blood Advances. 2024-11-12 - Evaluating serum free light chain ratio as a biomarker in multiple myeloma.Theresia Akhlaghi, Kylee Maclachlan, Neha Korde, Sham Mailankody, Alexander Lesokhin
Haematologica. 2024-10-03
Abstracts/Posters
- A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...Oscar B Lahoud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (wKRd-D) Combination Therapy Provides Unprecedented MRD Negativity Rates in Newly Diagnosed Multiple My...Oscar B Lahoud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...Oscar B Lahoud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
Renowned Blood Cancer Expert Named NYU Langone Hospital—Brooklyn’s New Section Chief of HematologySeptember 9th, 2024
Memorial Sloan Kettering and New York Cancer and Blood Specialists Partner on New Flatbush Cancer Care CenterApril 5th, 2023- NYU Langone Health Leader Discusses Vision to Enhance Care & Make Life Easier for People with CancerApril 23rd, 2024
Professional Memberships
- Member
- Member
- Member
- Member
- American Society for Blood and Marrow Transplantation - ASBMTMember
Other Languages
- Arabic, French, German
External Links
- Websitehttps://nyulangone.org/doctors/1972731776/oscar-b-lahoud
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
